Kayla Kimes
Psychiatric/Mental Health · Tinley Park, ILNPI 1396470191
Payments from drug & device makers
Across 233 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$803
- Corium, LLC$597
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$485
- Lundbeck LLC$410
- Johnson & Johnson$379
- Otsuka America Pharmaceutical, Inc.$377
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $803 |
| Corium, LLC | 21 | $597 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 23 | $485 |
| Lundbeck LLC | 21 | $410 |
| Johnson & Johnson | 13 | $379 |
| Otsuka America Pharmaceutical, Inc. | 16 | $377 |
| Tris Pharma Inc | 20 | $321 |
| Alkermes, Inc. | 12 | $249 |
| Axsome Therapeutics, Inc. | 9 | $226 |
| Teva Pharmaceuticals USA, Inc. | 9 | $217 |
| Vanda Pharmaceuticals Inc. | 7 | $209 |
| Neurocrine Biosciences, Inc. | 8 | $189 |
| Idorsia Pharmaceuticals US Inc | 9 | $140 |
| Indivior Inc. | 4 | $114 |
| E.r. Squibb & Sons, L.L.C. | 4 | $95 |
| Almatica Pharma LLC | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Orexo US, Inc. | 2 | $44 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Bausch Health US, LLC | 2 | $26 |
| Biogen | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $21 |
| Neos Therapeutics, LP | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$5,179 in reported general payments places this provider in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 53 | $80,048 |
| Invega SustennaPaliperidone Palmitate | 15 | $51,866 |
| CaplytaLumateperone Tosylate | 12 | $19,454 |
| RexultiBrexpiprazole | 15 | $18,659 |
| Paliperidone ErPaliperidone | 17 | $3,912 |
| Bupropion XlBupropion Hcl | 113 | $2,483 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 72 | $2,293 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 66 | $2,195 |
| Aripiprazole | 92 | $1,873 |
| Olanzapine | 66 | $1,590 |
| Escitalopram Oxalate | 135 | $1,577 |
| Memantine Hcl | 28 | $1,577 |
| Quetiapine Fumarate | 85 | $1,543 |
| Ziprasidone Hcl | 36 | $1,508 |
| Mirtazapine | 139 | $1,505 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $803 | $80,04853 claims |
| Johnson & JohnsonInvega Sustenna | $379 | $51,86615 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $485 | $19,45412 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $377 | $18,65915 claims |
| Almatica Pharma LLCSertraline Hcl | $66 | $42643 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Tinley Park
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.